Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 8,127 | 0 | 0 | 13,819 | 26,741 |
Cost of Goods | N/A | N/A | N/A | N/A | 2,500 |
Gross Profit | 8,127 | N/A | N/A | 13,819 | 24,241 |
Operating Expenses | 128,066 | 124,567 | 102,487 | 92,457 | 79,273 |
Operating Income | -119,939 | -124,567 | -102,487 | -78,638 | -54,532 |
Interest Expense | 10,929 | 10,754 | 4,010 | 3,040 | 2,113 |
Other Income | 701 | -893 | 2,415 | -2,473 | -4,019 |
Pre-tax Income | -130,167 | -136,214 | -104,082 | -84,151 | -60,664 |
Net Income Continuous | -130,167 | -136,214 | -104,082 | -84,151 | -60,664 |
Minority Interests | -14,308 | -15,180 | -12,232 | -10,693 | -684 |
Net Income | $-115,859 | $-121,034 | $-91,850 | $-73,458 | $-59,980 |
EPS Basic Total Ops | -0.98 | -1.03 | -0.78 | -0.60 | -0.51 |
EPS Basic Continuous Ops | -1.10 | -1.16 | -0.88 | -0.68 | -0.52 |
EPS Diluted Total Ops | -0.98 | -1.03 | -0.78 | -0.60 | -0.51 |
EPS Diluted Continuous Ops | -1.10 | -1.16 | -0.88 | -0.68 | -0.52 |
EBITDA(a) | $-120,954 | $-123,072 | $-101,946 | $-78,638 | $-54,532 |